Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 34521113

Phase 1a/b study of monoclonal antibody CAEL-101 (11-1F4) in patients with AL amyloidosis.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2021 Dec 23
First author
Edwards CV

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2021 Dec 23;138(25):2596-2598. doi: 10.1182/blood.2021013817.
    note
    Source null
    related pmid
    34940822
    relationship
    Comment in

Authors and identifiers

  1. name
    Edwards CV
    type
    Author
  2. name
    Rao N
    type
    Author
  3. name
    Bhutani D
    type
    Author
  4. name
    Mapara M
    type
    Author
  5. name
    Radhakrishnan J
    type
    Author
  6. name
    Shames S
    type
    Author
  7. name
    Maurer MS
    type
    Author
  8. name
    Leng S
    type
    Author
  9. name
    Solomon A
    type
    Author
  10. name
    Lentzsch S
    type
    Author
  11. name
    Eisenberger A
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Edwards CV
    type
    Author
  2. name
    Rao N
    type
    Author
  3. name
    Bhutani D
    type
    Author
  4. name
    Mapara M
    type
    Author
  5. name
    Radhakrishnan J
    type
    Author
  6. name
    Shames S
    type
    Author
  7. name
    Maurer MS
    type
    Author
  8. name
    Leng S
    type
    Author
  9. name
    Solomon A
    type
    Author
  10. name
    Lentzsch S
    type
    Author
  11. name
    Eisenberger A
    type
    Author
bibliography ids
  1. nci-bib-45f66fb0e4bfcdaaa41f4d57
book metadata
content sha256
f39887448ad1df283c1af5dbc32cb9d13ff495f969689e254fbdfc3c04a4ea09
document type
citation
dois
  1. 10.1182/blood.2020009039
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:34521113
immutable id
pubmed:34521113@f39887448ad1df283c1af5dbc32cb9d13ff495f969689e254fbdfc3c04a4ea09
journal
abbreviation
Blood
issn electronic
1528-0020
issn print
0006-4971
issue
25
name
Blood
nlm unique id
7603509
pages
2632-2641
volume
138
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2021 Dec 23;138(25):2596-2598. doi: 10.1182/blood.2021013817.
    note
    Source null
    related pmid
    34940822
    relationship
    Comment in
outcomes validated
false
pmid
34521113
provenance
batch id
192b6392c165c6b06274
provider
NCBI PubMed ESummary
record sha256
4d2d9b293a9e789e6e95cdffe5824a7531db246d732758fa0ac721a8801e55b4
response sha256
7d81e9fb11ee99e6ad4116aecd61ba71cd6bf76f2a8f8f6d15c5c85e9c6c56b4
retrieved at
2026-09-09T23:48:02.713075+00:00
publication date
display
2021 Dec 23
precision
day
year
2021
publication types
  1. Clinical Trial, Phase I
  2. Journal Article
  3. Research Support, N.I.H., Extramural
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/34521113/
title
Phase 1a/b study of monoclonal antibody CAEL-101 (11-1F4) in patients with AL amyloidosis.

Preserved source evidence · Not medical advice